Prevalence of and risk factors for methamphetamine use in northern Thai youth: results of an audio-computer-assisted self-interviewing survey with urine testing.
OBJECTIVE
Data from drug treatment facilities, drug seizures and drug arrests suggest rapidly increasing methamphetamine use by adolescents in Thailand. However, limited quantitative data are available about the prevalence of its use or correlates of use. The purpose of our study was therefore to estimate the prevalence of methamphetamine use and to identify possible risk factors.


METHODS
Cross-sectional survey using anonymous audio-computer-assisted self-interview and urine specimen analysis.


METHODS
Chiang Rai Province, Thailand.


METHODS
1725 students, 15-21 years of age (893 male and 832 female) attending one of three vocational schools in Chiang Rai Province.


RESULTS
Three hundred and fifty male and 150 female students reported a history of having ever used methamphetamine. In addition, 128 male and 49 female students had positive urine test results, indicating recent methamphetamine use; 27 of these students denied having ever used methamphetamine. According to history, urine test, or both, 41.3% of male students and 19.0% of female students used methamphetamine. In multivariate analysis, methamphetamine use was highly correlated with the use of other substances, sexual activity, peer pressure, positive attitudes toward methamphetamine, and absence of a family confidant.


CONCLUSIONS
Methamphetamine use is common among adolescent students in northern Thailand. Demographic, behavioral and psychosocial correlates of methamphetamine use identified in this study may be helpful for the design and implementation of preventive interventions.
Division of HIV/AIDS Prevention, National Center for HIV, Atlanta, GA, USA.
Martin V
MV
Sattah
Somsak
S
Supawitkul
Timothy J
TJ
Dondero
Peter H
PH
Kilmarx
Nancy L
NL
Young
Timothy D
TD
Mastro
Supaporn
S
Chaikummao
Chomnad
C
Manopaiboon
Frits van
Fv
Griensven
D000293:Adolescent; D000294:Adolescent Behavior / Q000523:psychology*; D000328:Adult; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000652:urine*; D016001:Confidence Intervals; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D016015:Logistic Models; D008297:Male; D008694:Methamphetamine / Q000009:adverse effects / Q000652:urine*; D015999:Multivariate Analysis; D016017:Odds Ratio; D015995:Prevalence; D012307:Risk Factors; D012984:Software; D019966:Substance-Related Disorders / Q000453:epidemiology* / Q000517:prevention & control / Q000523:psychology; D013785:Thailand / Q000453:epidemiology
D000697:Central Nervous System Stimulants; D008694:Methamphetamine